US Patent Issued on Dec. 23 for "Hydroxyprogesterone caproate compositions and methods of use in preventing preterm birth" (Utah Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,396, issued on Dec. 23.

"Hydroxyprogesterone caproate compositions and methods of use in preventing preterm birth" was invented by Kilyoung Kim (Salt Lake City), Nachiappan Chidambaram (Salt Lake City), Mahesh V. Patel (Salt Lake City), Benjamin J. Bruno (Salt Lake City) and Shadi Mehraban (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "An HPC composition and method of treatment for the prevention of PTB and improved neonatal outcomes. The invention provides for a dosing regimen beginning as early as 14 weeks of fetal gestation and dosing regimens of a duration of as much as 25 weeks. The invention provides a high level of exogeneous ...